Clinical Trial Update: Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US)

View source ↗

Summary

ClinicalTrials.gov update indicates that the long-term safety and clinical outcomes study of Livmarli (maralixibat) for Alagille syndrome and Progressive famili…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alagille Syndrome
• Progressive Familial Intrahepatic Cholestasis

Drugs mentioned

• LIVMARLI (Maralixibat chloride)

Snippet

Sponsor: Mirum Pharmaceuticals, Inc. | Conditions: Alagille Syndrome, Progressive Familial Intrahepatic Cholestasis | Status: RECRUITING